✦ LIBER ✦

49 Paclitaxel (P) by 1 or 24 hour (HR) infusion combined with carboplatin (C) in advanced non-small cell lung carcinoma (NSCLC): A comparative analysis

✍ Scribed by Langer, C.; McAleer, C.; Bonjo, C.; Ozols, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paclitaxel by 1-h infusion in combinatio

✍ C.J. Langer; C.A. McAleer; C.A. Bonjo; S. Litwin; M. Millenson; R. Kosierowski; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 263 KB

Paclitaxel by 24- or 1-hour infusion in

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 146 KB

O-217 A randomized phase III trial of ge

✍ Treat, Joe; Chandra, Belani P.; Edelman, Martin; Socinski, Mark; Gonin, R.; Ansa 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 170 KB

9003 ORAL Biomarker Analysis in BO21015,

✍ Mok, T.; Gorbunova, V.; Juhasz, E.; Szima, B.; Burdaeva, O.; Yu, C.J.; Delmar, P 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

1231 A phase I study of axitinib (AG-013

✍ M.F. Kozloff; L.P. Martin; M. Krzakowski; T.A. Samuel; J. Tarazi; B. Rosbrook; M 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

6508 ORAL CP-751, 871, an anti-IGF-IR an

✍ Paz-Ares, L.; Pollak, M.N.; Eisenberg, P.D.; Blakely, L.J.; Haluska, P.; Cohen, 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 77 KB